Literature DB >> 12700989

[Postoperative ileus: part I (Experimental results)].

M S Kasparek1, M E Kreis, E C Jehle, T T Zittel.   

Abstract

Postoperative gastro-intestinal motility disorders are of major importance for patient management following abdominal surgery both for clinical and economic reasons. In recent years, new pathophysiological links have been identified that contribute to postoperative ileus. The activation of sympathetic efferent neurons by visceral afferent nerve fibers, catecholamines, the stimulation of beta 3 -receptors in the gut wall, an inflammatory response of the gut wall with the consecutive release of nitric oxide, and opioids given for postoperative analgesia seem to be of major importance regarding the development of postoperative ileus. The pharmacological reduction of visceral afferent nerve fiber activity, non-steroidal anti-inflammatory drugs (NSAIDs) instead of opioids for postoperative pain, peripheral opioid receptor antagonists together with opioids for postoperative analgesia, motilides and 5-HT4 receptor agonists as prokinetic drugs are strategies that are currently evaluated to treat postoperative ileus. Our review summarizes the present knowledge on the pathophysiology of postoperative ileus and new experimental treatments that might be of importance in the future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700989     DOI: 10.1055/s-2003-38796

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  Role of the vagus nerve on the development of postoperative ileus.

Authors:  Zhirong Gao; Mario H Müller; Martina Karpitschka; Sarah Mittler; Michael S Kasparek; Bernhard Renz; Andrej Sibaev; Jörg Glatzle; Yongyu Li; Martin E Kreis
Journal:  Langenbecks Arch Surg       Date:  2010-03-24       Impact factor: 3.445

2.  Vagal innervation and early postoperative ileus in mice.

Authors:  Mario H Mueller; Martina Karpitschka; Zhirong Gao; Sarah Mittler; Michael S Kasparek; Bernhard Renz; Andrej Sibaev; Jörg Glatzle; Yongyu Li; Martin E Kreis
Journal:  J Gastrointest Surg       Date:  2011-03-25       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.